Global Health Limited — Investor Meet, 20-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Medanta posted strong Q4 FY26 results with Total Income up 25% YoY to INR 1,195.8 Cr and PAT surging 40% to INR 141.7 Cr. FY26 saw revenue growth of 20% to INR 4,508.9 Cr.

Noida hospital's Q4 EBITDA loss narrowed to INR 23.6 Cr, with management projecting break-even by H2 FY27 as it ramps up operations and empanelments. The company plans significant expansion, adding 500 beds across existing hospitals and 2,700 beds via five greenfield projects (INR 4,500 Cr capex over 5 years). Strong clinical talent and procedural capacity additions are key growth drivers. Management is optimistic about continued demand and strategic expansions.